Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis
ClinicalTrials.gov study NCT00548262. IPD Sharing: Not stated. Countries: 5. Publications: 5.
A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Treatment of Physician's Choice in Subjects With Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT01454934. IPD Sharing: Not stated. Countries: 14. Publications: 1.
Arterial Spin Labeling MRI Focal Abnormalities in Refractory Epilepsy
ClinicalTrials.gov study NCT01772654. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Multicenter Study of the Efficacy and Safety of JZP-258 in the Treatment of Idiopathic Hypersomnia (IH) With an Open-label Safety Extension
ClinicalTrials.gov study NCT03533114. IPD Sharing: NO. Countries: 8. Publications: 3.
A Phase 3B, Open Label, Multi-Center Study to Evaluate the Safety, Tolerability and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Alone to Healthy Infants According
ClinicalTrials.gov study NCT01339923. IPD Sharing: Not stated. Countries: 4. Publications: 3.
Effect of Nutrition Labeling on Fast Food Choices
ClinicalTrials.gov study NCT00127660. IPD Sharing: Not stated. Countries: 1. Publications: 3.
An Open-label, Randomized, Crossover Study of Comparative Pharmacokinetics and Bioequivalence of Dapagliflozin + Metformin, 10 mg + 1000 mg Versus the Combined Use of Forxiga™, 10 mg and Two Glucophag
ClinicalTrials.gov study NCT02722239. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open Label Trial of Stribild for Antiretroviral (ARV)-naïve HIV-2 Infected Adults in Dakar, Senegal
ClinicalTrials.gov study NCT02180438. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal
ClinicalTrials.gov study NCT01863186. IPD Sharing: Not stated. Countries: 1. Publications: 3.
4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures
ClinicalTrials.gov study NCT00368472. IPD Sharing: Not stated. Countries: 14. Publications: 2.
A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066
ClinicalTrials.gov study NCT01130493. IPD Sharing: NO. Countries: 4. Publications: 1.
Study of Open Label Losartan in COVID-19
ClinicalTrials.gov study NCT04335123. IPD Sharing: YES. Countries: 1. Publications: 1.
A Phase III, Open-Label Study of Maintenance Lurbinectedin in Combination With Atezolizumab Compared With Atezolizumab in Participants With Extensive-Stage Small-Cell Lung Cancer
ClinicalTrials.gov study NCT05091567. IPD Sharing: YES. Countries: 13. Publications: 1.
An Open-Label Study of Telaprevir Administered Every 12 or 8 Hours in Combination With One of Two Pegylated Interferons and Ribavirin in Treatment-Naive Genotype 1 Chronic Hepatitis C Participants
ClinicalTrials.gov study NCT00528528. IPD Sharing: Not stated. Countries: 6. Publications: 1.
A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD
ClinicalTrials.gov study NCT01371721. IPD Sharing: Not stated. Countries: 2. Publications: 1.
An Open-label, Phase 2 Study of ACP-196 in Subjects With Waldenström Macroglobulinemia
ClinicalTrials.gov study NCT02180724. IPD Sharing: YES. Countries: 7. Publications: 2.
A Phase I, Open-label Study to Assess Bioavailability of a Single Oral Dose of AZD9291 vs an IV Dose of [14C]AZD9291
ClinicalTrials.gov study NCT02491944. IPD Sharing: Not stated. Countries: 1. Publications: 1.
An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis
ClinicalTrials.gov study NCT01772823. IPD Sharing: Not stated. Countries: 1. Publications: 2.
An Open-Label Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of OV101 in Individuals With Angelman Syndrome
ClinicalTrials.gov study NCT03882918. IPD Sharing: NO. Countries: 2. Publications: 1.
Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy
ClinicalTrials.gov study NCT00160654. IPD Sharing: Not stated. Countries: 6. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.